Sanara Medtech earnings were -$32.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SMTI earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$452.9k, down 198.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SMTI reported annual earnings of -$37.6M, with 288.7% growth. The next SMTI earnings date is Nov 11, 2026.
On SMTI's earnings call on Aug 12, 2026, Sanara Medtech (NASDAQ: SMTI) reported Q2 2026 earnings per share (EPS) of -$0.05, up 78.26% year over year. Total SMTI earnings for the quarter were -$452.86 thousand. In the same quarter last year, Sanara Medtech's earnings per share (EPS) was -$0.23.
The next SMTI earnings call is Nov 11, 2026. Add SMTI to your watchlist to be reminded of Sanara Medtech's next earnings date.
Is Sanara Medtech profitable or losing money?
As of the last Sanara Medtech earnings report, Sanara Medtech is currently losing money. Sanara Medtech's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$32.01 million, a 222.15% increase year over year.
What was SMTI's earnings growth in the past year?
As of Sanara Medtech's earnings date in Aug 12, 2026, Sanara Medtech's earnings has grown year over year. SMTI earnings in the past year totalled -$32.01 million.
What are Sanara Medtech's earnings expectations?
The current EPS estimate for Sanara Medtech's earnings report in Nov 11, 2026 is $0.06.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.